White House announces 15 new drugs for Medicare price negotiation
AP News • • business
Key Points:
- The Trump administration announced 15 new medications, including drugs for Type 2 diabetes, HIV, and arthritis, selected for Medicare's drug price negotiation program, allowing the federal government to negotiate directly with manufacturers to reduce costs.
- These drugs, which are among the most expensive and widely used by Medicare enrollees, could lead to significant taxpayer savings when negotiated prices take effect in 2028.
- This is the third round of negotiations under the 2022 law, expanding for the first time to include Medicare Part B outpatient drugs alongside Part D retail prescriptions.
- Notable drugs on the list include Trulicity for diabetes, Biktarvy for HIV, and Botox for Medicare-covered treatments, with approximately 1.8 million Medicare en
